entertainment -WSS

entertainment

author：entertainment 2025-09-27 09:59:03 - browse：539

Mel Evans/AP

Merck announced Monday it will acquire Harpoon Therapeutics and its pipeline of immune-based cancer drugs for $680 million. Merck will pay $23 per share, just over twice Harpoon’s market price entering the week.

The bolt-on deal comes as Merck’s top brass searches for ways to bolster the company’s revenue after it loses exclusivity on Keytruda, long the world’s most lucrative cancer drug. That could come as soon as 2028.

Keytruda, a PD-(L)1 inhibitor, works by turning off a “brake” on T cells, allowing roving immune cells to attack tumors. Harpoon’s pipeline belongs to a new class of cancer drugs designed to grab onto the T cells and tumor cells and bring them together.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： FDA's naming rule on biosimilars has undermined competition

hotspot

WSS

Peter Marks talks Operation Warp Speed for Rare Diseases

STAT Readout: Today's biotech news includes Sana and Amylyx

Washington mulls new rules to avert another Change Healthcare

Bernie Sanders bashes nonprofit hospitals over their tax breaks

Peter Marks talks Operation Warp Speed for Rare Diseases

How should state employee insurance handle Wegovy?

focus

entertainment

leisure time

Medical records are filled with copy

Readout LOUD podcast: mifepristone case, GLP

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Food as medicine: Medically tailored meals may get standardized

As demand for Covid shots wanes, Moderna seeks its next success

Researchers CRISPR chickens in bid to protect them from bird flu

Hollywood unions extend contract negotiations for actors

Cancer cells are shown to suck energy source from immune cells

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Eliminate the waiting period for sterilization covered by Medicaid

focus

Primary care physicians play key roles in Alzheimer's management

Massive project maps cells in human brain in unprecedented detail

Scientists boost immune system in aging mice by making it youthful

Cancer cells are shown to suck energy source from immune cells

Covid vaccine financial winners and losers, from Pfizer to Novavax

Kidney disease boosts cardiac arrest risk for Hispanics, Latinos

explore

hotspot

hotspot

Wikipedia